Table 6.
Comparison of participant’s responses about source of contraception and availability of medical care for contraception-related complications before and after the COVID-19 pandemic
| Six months before COVID-19 (control), % (n) | During total curfew, % (n) | P-value | After total curfew, % (n) | P-value | |
|---|---|---|---|---|---|
| Source of contraception | |||||
| Maternity and childhood centers/health centers | 14.8 (28) | 7.0 (14) | 0.001 | 9.5 (19) | 0.022 |
| Pharmacies | 18.5 (37) | 16.5 (33) | 0.481 | 17.0 (34) | 0.607 |
| Private clinics | 9.5 (19) | 8.5 (17) | 0.500 | 9.0 (18) | 1.000 |
| Method used does not need external source | 19.0 (38) | 17.5 (35) | 0.549 | 19.5 (39) | 1.000 |
| No need to renew contraception (e.g., it is long acting) | 3.0 (6) | 3.5 (7) | 1.000 | 4.0 (8) | 0.625 |
| Have extra contraception | 1.5 (3) | 5.5 (11) | 0.021 | 2.5 (5) | 0.687 |
| No available source because of total lockdown | 0.0 (0) | 1.0 (2) | NA | 0.0 (0) | NA |
| No medical care for contraception complications | 0.0 (0) | 5.5 (11) | NA | 4.0 (8) | NA |
NA = not applicable.